Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

The Westin Boston Seaport District

Mar 02, 2026 11:00 AM - Mar 04, 2026 12:30 PM

425 Summer Street, Boston, MA 02210, USA

Medical Affairs and Scientific Communications Forum

The longest running neutral forum cultivating interdepartmental relationships in medical affairs.

Hosted Session/Non-CE: Case Study hosted by AlphaLife Sciences How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control[

Session Chair(s)

  Sponsored Sessions

Sponsored Sessions

United States

As regulatory and medical writing demands grow, pharmaceutical companies are adopting AI to accelerate document creation while ensuring quality and compliance. Automating CSRs, protocols, IBs, and CTD modules reduces manual effort and frees teams to focus on higher-value tasks. However, in regulatory environments, automation must also ensure accuracy, auditability, and traceability to meet compliance standards.

Learning Objective :

Featured Topics:

  • Growing demand for faster, compliant medical and regulatory document generation
  • Use of AI to automate CSRs, protocols, IBs, and CTD modules
  • Benefits: reduced manual effort and accelerated timelines
  • Importance of quality control in high-stakes regulatory contexts
  • Ensuring AI systems deliver accuracy, auditability, and traceability

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.